Classification of inherited von Willebrand disease and implications in clinical practice

Thrombosis Research

Volumn 124, Issue SUPPL. 1, 2009, Pages S2-

  Federici, Augusto B ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Classification; Diagnosis; Factor VIII; Von Willebrand disease; Von Willebrand factor

Indexed keywords

ANTIFIBRINOLYTIC AGENT; DESMOPRESSIN; GLYCOPROTEIN IB ALPHA; IRON; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL PRACTICE; CURETTAGE; DISEASE CLASSIFICATION; EPISTAXIS; GENE MUTATION; HUMAN; IRON THERAPY; LABORATORY TEST; MEDICAL DECISION MAKING; MENORRHAGIA; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SUBSTITUTION THERAPY; TREATMENT RESPONSE; VON WILLEBRAND DISEASE;

EID: 71549169525     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(09)70150-1     Document Type: Article

References (12)

1. Rodeghiero F., Castaman G., and Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 69 (1987) 454-459
2. Ruggeri Z.M. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 1 (2003) 1335-1342
3. Ruggeri Z.M., Mannucci P.M., Lombardi R., Federici A.B., and Zimmerman T.S. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implication for pathophysiology and therapy of von Willebrand's disease subtypes. Blood 59 (1982) 1272-1278
4. Sadler J.E., Budde U., Eikenboom J.C.J., Favaloro E.J., Hill F.G.H., Holmberg L., et al. Updated on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 4 (2006) 2103-2114
5. Federici A.B., and Canciani M.T. Clinical and laboratory versus molecular markers for a correct classification of von Willebrand disease. Haematologica 94 (2009) 610-615
6. Tosetto A., Rodeghiero F., Castaman G., Goodeve A., Federici A.B., Batlle J., et al. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 4 (2006) 766-773
7. Nichols W.L., Hultin M.B., James A.H., Manco-Johnson M.J., Montgomery R.R., Ortel T.L., et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel Report (USA). Haemophilia 14 (2008) 171-232
8. Federici A.B., Canciani M.T., Forza I., Mannucci P.M., Marchese P., Ware J., et al. A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibα for the diagnosis of patients with low von Willebrand factor levels. Haematologica 89 (2004) 77-85
9. Tosetto A., Castaman G., and Rodeghiero F. Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approach. Blood 111 (2008) 3998-4003
10. Federici A.B., Mazurier C., Berntorp E., Lee C.A., Scharrer I., Goudemand J., et al. Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study. Blood 103 (2004) 2032-2038
11. Federici A.B., Mannucci P.M., Castaman G., Baronciani L., Bucciarelli P., Canciani M.T., et al. Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients. Blood 113 (2009) 526-534
12. Rodeghiero F., Castaman G., and Tosetto A. How I treat von Willebrand disease. Blood 114 (2009) 1158-1165